{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hepatitis-a/diagnosis/diagnosis/","result":{"pageContext":{"chapter":{"id":"94f8b729-5e94-57ee-b96e-ca1561614640","slug":"diagnosis","fullItemName":"Diagnosis","depth":2,"htmlHeader":"<!-- begin field aae44497-5bf0-43fa-8fe8-682353a2ac32 --><h2>How do I know my patient has it?</h2><!-- end field aae44497-5bf0-43fa-8fe8-682353a2ac32 -->","summary":"","htmlStringContent":"<!-- begin item 7fe9dcaf-dd70-4d3f-a2f1-291d30af179c --><!-- begin field c70306b6-7e5f-44f8-960b-0e0c03c5dd1f --><ul><li><strong>Public Health England uses the following case definitions for hepatitis A:</strong><ul><li><strong>Clinical case (possible):</strong><ul><li>A person with an acute illness, discrete onset of symptoms AND jaundice or elevated serum aminotransferase levels. For further information, see the sections on <a class=\"topic-reference internal-reference\" href=\"/topics/hepatitis-a/diagnosis/clinical-features/\">clinical features</a> and <a class=\"topic-reference internal-reference\" href=\"/topics/hepatitis-a/diagnosis/investigations/\">liver function tests</a>.</li></ul></li><li><strong>Probable case</strong>:<ul><li>Meets the clinical case definition (above) <em>and </em>has an epidemiological link to a confirmed hepatitis A case, <em>OR </em></li><li>Meets the clinical case definition <em>and</em> has IgM antibody to the hepatitis A virus (<a class=\"topic-reference internal-reference\" href=\"/topics/hepatitis-a/diagnosis/investigations/\">anti HAV IgM</a>).</li></ul></li><li><strong>Confirmed case:</strong><ul><li>Meets the clinical case definition <em>and</em> has IgM and IgG antibodies to hepatitis A, <em>OR</em></li><li>Has hepatitis A RNA (HAV RNA) detected regardless of clinical features, <em>OR </em></li><li>Is asymptomatic with no recent history of immunisation, but has anti HAV IgM in oral fluid or serum, <em>and</em> has an epidemiological link to a confirmed hepatitis A case.</li></ul></li></ul></li></ul><!-- end field c70306b6-7e5f-44f8-960b-0e0c03c5dd1f --><!-- end item 7fe9dcaf-dd70-4d3f-a2f1-291d30af179c -->","topic":{"id":"29ac65ab-afdd-58a1-bb07-9c101977d24d","topicId":"580cfa7a-647b-439a-8f8c-493cb6bd4332","topicName":"Hepatitis A","slug":"hepatitis-a","lastRevised":"Last revised in January 2021","chapters":[{"id":"d47cd8cf-fe05-5aa4-997b-01a20519d12f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8bbe6550-f4f5-5279-9e9e-04b38f9dc672","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"75791cbd-6d69-555e-83e8-9ac8cca25c50","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"c0ae1a2d-febe-5ec7-821a-0616062456ee","slug":"changes","fullItemName":"Changes"},{"id":"434eb73d-f60d-5f1f-ba10-5aa77d904da1","slug":"update","fullItemName":"Update"}]},{"id":"242c9e8c-5867-5598-9168-62160e8ae293","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"6c2f4656-f9e8-56be-aa43-3f6a9aa45aa8","slug":"goals","fullItemName":"Goals"},{"id":"71c0a726-22c7-568b-b925-d10cc97ace3a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"70e8a1cd-fd5b-50d7-8ce4-b6f29981218d","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"37bb7a58-62c9-52be-b97c-7b99f8317f12","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"badbd40f-9ce6-5f8a-9f65-8be03bc8d3fe","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"ed9f7297-1f33-5365-8e4f-3844542af45d","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"b6a11034-e31c-5039-8ca7-b463c00b2039","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"a2206363-5f44-5348-b469-07b49a6a9647","slug":"definition","fullItemName":"Definition"},{"id":"dd1ca873-1bf9-500d-a574-fc92c8589e62","slug":"prevalence","fullItemName":"Prevalence"},{"id":"bdd89354-2f0b-564c-b589-cb043e32b99c","slug":"transmission","fullItemName":"Transmission"},{"id":"8e72bb81-12fd-5a0e-976b-d18d62788974","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"ab3f5823-00db-5e27-a434-c323c357ab02","slug":"complications-prognosis","fullItemName":"Complications and prognosis"}]},{"id":"e879b74c-3d75-59c5-806e-4b39a6e72901","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"94f8b729-5e94-57ee-b96e-ca1561614640","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"6b32fed7-c15e-5976-adc6-692994cbab9e","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"2503640c-54cf-53e1-b29c-fc9c19cbd52a","slug":"investigations","fullItemName":"Investigations"},{"id":"88a35298-3760-53b6-b4ff-b9e0677b4df3","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"9ba7b244-14ec-5fd1-9b2b-151b9c48bfab","fullItemName":"Management","slug":"management","subChapters":[{"id":"1a3874e3-8562-5ca6-8c97-4d9a2a009e75","slug":"prevention-of-infection-with-hepatitis-a","fullItemName":"Scenario: Prevention of infection with hepatitis A"},{"id":"49c1d671-61dd-5a60-974f-069b03d80d11","slug":"managing-hepatitis-a-infection","fullItemName":"Scenario: Managing hepatitis A infection"},{"id":"449ffa79-3397-54a1-a4d5-0efa55ee889f","slug":"contact-with-hepatitis-a","fullItemName":"Scenario: Contact with hepatitis A"}]},{"id":"8ffd203a-96db-5a38-a7bd-0186b97b6600","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"7d022e5d-ab4e-50bf-b90f-5611cf3a17db","slug":"hepatitis-a-vaccine","fullItemName":"Hepatitis A vaccine"},{"id":"7d0e86fd-3666-5a09-b539-4497227285ee","slug":"analgesia","fullItemName":"Analgesia"},{"id":"0ee2b156-78a9-52f6-ab80-fff22c46ff66","slug":"anti-emetics","fullItemName":"Anti-emetics"},{"id":"508e578c-aa68-5cdb-aa90-ef8889919c08","slug":"anti-pruritics","fullItemName":"Anti-pruritics"}]},{"id":"bf6b787f-fbb7-5d8d-bd85-cfe063c76fcd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e0bba353-de5a-55b9-9171-a677ecc4b97a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2571e87f-4ad0-5f6d-8c0e-8c9c86054278","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"94bd9363-8cd1-5ba6-8fd3-11f5a3ce29dd","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"2db0f1a2-7d4b-5fd2-a8bf-db32553e5b89","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"29233885-dedb-5c3b-ba7e-1aae299ecfe2","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"0a3a365f-c89a-5f1e-8ce5-1078ade19779","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"1afe9613-76a4-50b9-8941-c2a2ebec23cc","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"e879b74c-3d75-59c5-806e-4b39a6e72901","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"8bec4790-e557-5b6e-810c-4e65cfaab0eb","slug":"basis-for-recommendation-03c","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 3e5cbd62-bd61-438a-a39d-e024c73d147e --><h3>Basis for recommendation</h3><!-- end field 3e5cbd62-bd61-438a-a39d-e024c73d147e -->","summary":null,"htmlStringContent":"<!-- begin item 03cd55d9-9ea8-4706-ba57-e8c49049990f --><!-- begin field e2e5b76e-0bee-48b1-b882-d4ceb30e86a6 --><p>The information on case definitions for hepatitis A is based on expert opinion in the Public Health England (PHE) guideline <em>Public health control and management of hepatitis A </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/hepatitis-a/references/\">PHE, 2017</a>].</p><!-- end field e2e5b76e-0bee-48b1-b882-d4ceb30e86a6 --><!-- end item 03cd55d9-9ea8-4706-ba57-e8c49049990f -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}